Compass Pathways Announces Third Quarter 2025 Financial Results and Business Highlights Including Acceleration of Commercial Launch Plans by 9-12 Months

Contributed by: Business Wire

Logo

Business Wire logo

Tags

Mental Health
Research
Biotechnology
Other Health
Alternative Medicine
Health
Pharmaceutical
Other Science
Science
Compass Pathfinder Limited

More Like This

Compass Pathways Announces First Quarter 2025 Financial Results and Business Highlights

Business Wire logo

Compass Pathways Announces Third Quarter 2024 Financial Results and Business Updates

Business Wire logo

Compass Pathways Announces Second Quarter 2025 Financial Results and Business Highlights

Compass Pathways Announces Fourth Quarter and Full-Year 2024 Financial Results and Business Highlights

Business Wire logo

Compass Pathways to Announce Second Quarter Financial Results on July 31, 2025

Business Wire logo

Compass Pathways to Announce Third Quarter Financial Results on November 4, 2025

Compass Pathways Announces Dosing Complete for All Participants in Part A of Phase 3 COMP005 Trial of COMP360 Psilocybin for Treatment-Resistant Depression

Compass Pathways Announces Completion of Recruitment for the Phase 3 COMP005 Trial of COMP360 Psilocybin for Treatment-Resistant Depression